Squarepoint Ops LLC Amgen Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Amgen Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 14,466 shares of AMGN stock, worth $3.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,466

Previous 45,500 68.21%

Holding current value

$3.85 Million

Previous $14.2 Million 67.21%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $2.38 Million - $2.59 Million	-7,687 Reduced 34.7%	14,466 $4.66 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $29.2 Million - $35.5 Million	-111,234 Reduced 83.39%	22,153 $6.92 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $32 Million - $38.6 Million	118,886 Added 819.85%	133,387 $37.9 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $119 Million - $134 Million	-463,983 Reduced 96.97%	14,501 $4.18 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $35.6 Million - $42.1 Million	166,100 Added 53.17%	478,484 $106 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $28 Million - $34.2 Million	124,193 Added 65.99%	312,384 $75.5 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14.7 Million - $18.7 Million	-64,282 Reduced 25.46%	188,191 $49.4 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $17.7 Million - $20 Million	-78,896 Reduced 23.81%	252,473 $56.9 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $56.9 Million - $63.3 Million	246,490 Added 290.4%	331,369 $80.6 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $7.08 Million - $7.83 Million	32,295 Added 61.42%	84,879 $20.5 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $16.6 Million - $19 Million	-83,302 Reduced 61.3%	52,584 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $12.9 Million - $15.1 Million	60,563 Added 80.4%	135,886 $28.9 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $11.7 Million - $13 Million	50,154 Added 199.27%	75,323 $18.4 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $11.9 Million - $13.9 Million	-53,815 Reduced 68.13%	25,169 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $17.1 Million - $20.4 Million	78,984 New	78,984 $18.2 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $507,184 - $622,385	-2,564 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $2.39 Million - $3.17 Million	-13,136 Reduced 83.67%	2,564 $520,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $23 Million - $29.6 Million	-121,660 Reduced 88.57%	15,700 $3.79 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $4.87 Million - $5.83 Million	27,960 Added 25.56%	137,360 $26.6 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $9.39 Million - $11 Million	56,300 Added 106.03%	109,400 $20.2 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $8.35 Million - $9.41 Million	46,163 Added 665.46%	53,100 $10.1 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $10.2 Million - $11.9 Million	-57,031 Reduced 89.16%	6,937 $1.35 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $7.39 Million - $8.33 Million	-39,892 Reduced 38.41%	63,968 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $12.7 Million - $14.2 Million	76,347 Added 277.49%	103,860 $19.2 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $3.92 Million - $4.58 Million	-23,154 Reduced 45.7%	27,513 $4.69 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $3.48 Million - $3.89 Million	20,603 Added 68.53%	50,667 $8.81 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $5.03 Million - $5.74 Million	30,064	30,064 $5.61 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Amgen Inc Transaction History